These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 32884613)
61. Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents. Nishijima S; Kurokawa I; Kawabata S J Int Med Res; 1996; 24(6):473-7. PubMed ID: 8959531 [TBL] [Abstract][Full Text] [Related]
62. Prevalence of antimicrobial-resistant Cutibacterium isolates and development of multiplex PCR method for Cutibacterium species identification. Koizumi J; Nakase K; Hayashi N; Nasu Y; Hirai Y; Nakaminami H J Infect Chemother; 2023 Feb; 29(2):198-204. PubMed ID: 36336238 [TBL] [Abstract][Full Text] [Related]
63. Susceptibility of Propionibacterium acnes isolated from patients with acne vulgaris to zinc ascorbate and antibiotics. Iinuma K; Noguchi N; Nakaminami H; Sasatsu M; Nishijima S; Tsuboi I Clin Cosmet Investig Dermatol; 2011; 4():161-5. PubMed ID: 22087070 [TBL] [Abstract][Full Text] [Related]
64. First Report of Plasmid-Mediated Macrolide-Clindamycin-Tetracycline Resistance in a High Virulent Isolate of Rana MS; Kim J; Kim S Pathogens; 2023 Oct; 12(11):. PubMed ID: 38003751 [No Abstract] [Full Text] [Related]
65. Biofilm of Cutibacterium acnes: a target of different active substances. Ruffier d'Epenoux L; Fayoux E; Veziers J; Dagnelie MA; Khammari A; Dréno B; Corvec S Int J Dermatol; 2024 May; ():. PubMed ID: 38760974 [TBL] [Abstract][Full Text] [Related]
66. A comparative study of Cutibacterium (Propionibacterium) acnes clones from acne patients and healthy controls. Lomholt HB; Scholz CFP; Brüggemann H; Tettelin H; Kilian M Anaerobe; 2017 Oct; 47():57-63. PubMed ID: 28434779 [TBL] [Abstract][Full Text] [Related]
67. Clonality and anatomic distribution on the skin of antibiotic resistant and sensitive Propionibacterium acnes. Lomholt HB; Kilian M Acta Derm Venereol; 2014 Sep; 94(5):534-8. PubMed ID: 24577497 [TBL] [Abstract][Full Text] [Related]
68. Scientific Rationale and Clinical Basis for Clindamycin Use in the Treatment of Dermatologic Disease. Armillei MK; Lomakin IB; Del Rosso JQ; Grada A; Bunick CG Antibiotics (Basel); 2024 Mar; 13(3):. PubMed ID: 38534705 [TBL] [Abstract][Full Text] [Related]
69. Association of Systemic Antibiotic Treatment of Acne With Skin Microbiota Characteristics. Chien AL; Tsai J; Leung S; Mongodin EF; Nelson AM; Kang S; Garza LA JAMA Dermatol; 2019 Apr; 155(4):425-434. PubMed ID: 30758497 [TBL] [Abstract][Full Text] [Related]
70. Cross-sectional Pilot Study of Antibiotic Resistance in Propionibacterium Acnes Strains in Indian Acne Patients Using 16S-RNA Polymerase Chain Reaction: A Comparison Among Treatment Modalities Including Antibiotics, Benzoyl Peroxide, and Isotretinoin. Sardana K; Gupta T; Kumar B; Gautam HK; Garg VK Indian J Dermatol; 2016; 61(1):45-52. PubMed ID: 26955094 [TBL] [Abstract][Full Text] [Related]
71. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates. Dréno B; Pécastaings S; Corvec S; Veraldi S; Khammari A; Roques C J Eur Acad Dermatol Venereol; 2018 Jun; 32 Suppl 2():5-14. PubMed ID: 29894579 [TBL] [Abstract][Full Text] [Related]
72. Recent advances in understanding Platsidaki E; Dessinioti C F1000Res; 2018; 7():. PubMed ID: 30613388 [TBL] [Abstract][Full Text] [Related]
73. Acne vulgaris: a review of antibiotic therapy. Tan AW; Tan HH Expert Opin Pharmacother; 2005 Mar; 6(3):409-18. PubMed ID: 15794732 [TBL] [Abstract][Full Text] [Related]
74. Draft genome sequences of three multidrug-resistant Cutibacterium (formerly Propionibacterium) acnes strains isolated from acne patients, China. Zhang N; Lu Z; Ma Y J Glob Antimicrob Resist; 2017 Dec; 11():114-115. PubMed ID: 29051020 [TBL] [Abstract][Full Text] [Related]
75. Propionibacterium acnes and antimicrobial resistance in acne. Dessinioti C; Katsambas A Clin Dermatol; 2017; 35(2):163-167. PubMed ID: 28274353 [TBL] [Abstract][Full Text] [Related]
76. Antibiotic resistance in the topical treatment of acne vulgaris. Leyden JJ Cutis; 2004 Jun; 73(6 Suppl):6-10. PubMed ID: 15228128 [TBL] [Abstract][Full Text] [Related]
77. Bacterial resistance to antibiotics in acne vulgaris: an in vitro study. Hassanzadeh P; Bahmani M; Mehrabani D Indian J Dermatol; 2008; 53(3):122-4. PubMed ID: 19882009 [TBL] [Abstract][Full Text] [Related]
78. Oral antibiotics in acne vulgaris: therapeutic response over 5 years. Adawiyah J; Priya G; Roshidah B Malays Fam Physician; 2010; 5(3):130-3. PubMed ID: 25606204 [TBL] [Abstract][Full Text] [Related]
79. Identification of a Transferable Linear Plasmid Carrying the Macrolide-Clindamycin Resistance Gene Koizumi J; Nakase K; Nakaminami H Microbiol Resour Announc; 2022 May; 11(5):e0009422. PubMed ID: 35438511 [TBL] [Abstract][Full Text] [Related]
80. A Myrtus communis extract enriched in myrtucummulones and ursolic acid reduces resistance of Propionibacterium acnes biofilms to antibiotics used in acne vulgaris. Feuillolay C; Pecastaings S; Le Gac C; Fiorini-Puybaret C; Luc J; Joulia P; Roques C Phytomedicine; 2016 Mar; 23(3):307-15. PubMed ID: 26969384 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]